ergotamine drug combination caffeine

06/24/1955 - "[Treatment of headache with cafergot]."
02/01/1951 - "Treatment of headache; Four new agents compared with Cafergot and E.C.B.-210."
01/01/1991 - "Sumatriptan was significantly more effective than Cafergot at reducing the intensity of headache from severe or moderate to mild or none; 66% (145/220) of those treated with sumatriptan improved in this way by 2 h, compared with 48% (118/246) of those treated with Cafergot (p less than 0.001). "
06/01/1992 - "There may be a higher rate of headache recurrence with sumatriptan compared with placebo or Cafergot, although further study is necessary to confirm this observation. "
01/01/2002 - "Eletriptan headache response rates at 1 h were significantly higher (80 mg, 39%; 40 mg, 29%; Cafergot, 13%; placebo, 13%; p < 0.002 for each comparison). "

01/01/1989 - "Cafergot P-B was significantly more effective than placebo in relieving head pain, nervous tension, nausea (second headache only), vomiting, and photphobia. "
01/01/1991 - "Nausea and/or vomiting, abdominal discomfort, and dizziness or vertigo were reported by a greater proportion of Cafergot-treated patients. "
01/01/1993 - "Associated symptoms such as nausea, vomiting and photophobia are effectively relieved by sumatriptan, whereas Cafergot provoked nausea and vomiting in a proportion of patients. "
01/01/2011 - "Gabapentin significantly reduced pain, nausea and vomiting compared to Cafergot in patients with PDPH. "
01/01/2011 - "Gabapentin group had less pain, nausea and vomiting compared to the Cafergot group. "

01/01/1993 - "Associated symptoms such as nausea, vomiting and photophobia are effectively relieved by sumatriptan, whereas Cafergot provoked nausea and vomiting in a proportion of patients. "
01/01/2002 - "Both doses of eletriptan were significantly more effective than Cafergot in reducing nausea (p < 0.0001), photophobia (80 mg, p < 0.0001; 40 mg, p < 0.002), phonophobia (80 mg, p < 0.0001; 40 mg, p < 0.003) and functional impairment (p < or = 0.001) at 2 h. "
01/01/1989 - "Cafergot P-B was significantly more effective than Cafergot in relieving head pain at hours 2 and 3, nervous tension, nausea, vomiting, anorexia, and photophobia. "
01/01/1991 - "Sumatriptan was also significantly more effective at reducing the incidence of nausea (p less than 0.001), vomiting (p less than 0.01) and photophobia/phonophobia (p less than 0.001) 2 h after treatment, and fewer patients on sumatriptan (24%) than on Cafergot (44%, p less than 0.001) required other medication after 2 h. "
01/01/1989 - "The results of this study show that addition of pentobarbital and Bellafoline to Cafergot provides greater relief of pain, vomiting, nervous tension, photophobia, and other symptoms associated with migraine, while reducing the severity of the nausea that may accompany a migraine headache or Cafergot therapy."

01/01/1989 - "The incidence of reported adverse effects was no greater with Cafergot P-B than with Cafergot; however, patients given Cafergot P-B reported less vomiting than did patients given Cafergot. "
01/01/1989 - "Cafergot P-B was significantly more effective than placebo in relieving head pain, nervous tension, nausea (second headache only), vomiting, and photphobia. "
01/01/1991 - "Nausea and/or vomiting, abdominal discomfort, and dizziness or vertigo were reported by a greater proportion of Cafergot-treated patients. "
01/01/1993 - "Associated symptoms such as nausea, vomiting and photophobia are effectively relieved by sumatriptan, whereas Cafergot provoked nausea and vomiting in a proportion of patients. "
01/01/2011 - "Gabapentin significantly reduced pain, nausea and vomiting compared to Cafergot in patients with PDPH. "

01/01/1989 - "Symptomatic relief of migraine: multicenter comparison of Cafergot P-B, Cafergot, and placebo."
03/31/1961 - "[Treatment of attacks of migraine with cafergot-P.B. "
01/01/1961 - "[Experience in the treatment of migraine with cafergot]."
12/01/1952 - "Treatment of severe migraine with cafergot."
03/01/1999 - "One patient had a history of Raynaud's disease, the second had been taking Cafergot for migraine headaches. "